RA.com Features Interactive Resource to Help People Living with Rheumatoid Arthritis
- Details
- Category: Abbott
As any do-it-yourselfer knows, a good home improvement project has both style and substance, adding functionality with aesthetic appeal. For people with rheumatoid arthritis (RA) who may face difficulties around the house, adaptable options around the home are particularly important.
New study results on Dulcolax® confirm efficacy and safety
- Details
- Category: Boehringer Ingelheim
In a clinical study Boehringer Ingelheim recently conducted, Dulcolax® tablets with the active ingredient bisacodyl clearly demonstrated efficacy by increasing the frequency and regularity of bowel movements.
GSK extends presence in Asia with new strategic alliance in South Korea
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline (GSK) entered into a strategic alliance with Dong-A Pharmaceuticals Co., Ltd. (Dong-A), the number one pharmaceutical and OTC Company in South Korea.
Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy
- Details
- Category: Merck
Merck & Co., Inc. (NYSE: MRK) hosted its first R&D and Business Briefing since completion of the Merck and Schering-Plough merger and outlined the company's strategy to drive global business growth.
Abbott licenses 24 Zydus pharmaceutical products for 15 high-growth emerging markets
- Details
- Category: Abbott
Further strengthening its global competitive position, Abbott (NYSE: ABT) announced a licensing and supply agreement with Zydus Cadila of India for a portfolio of pharmaceutical products that Abbott will commercialize in 15 emerging markets, enabling the company to further accelerate its emerging markets growth.
GSK Statement on FDA Advisory Committee meeting on Rotavirus vaccines
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline (NYSE: GSK) participated in a U.S. Food and Drug Administration (FDA) advisory committee meeting convened to discuss recent findings of porcine circovirus (PCV) in rotavirus vaccines.
EDUCARE (EDUcation for Cancer in African REgions) Project
- Details
- Category: Roche
Roche announced the launch of the EDUCARE (EDUcation for Cancer in African REgions) project, which, in concert with IAEA (International Atomic Energy Agency), will provide support to help combat the growing cancer epidemic in sub-Saharan Africa.
More Pharma News ...
- Bayer Schering Pharma Initiates Phase III Trial of Regorafenib
- Bayer Schering Pharma Initiates Phase III Trial of Regorafenib (BAY 73-4506)
- Lundbeck delivers strong growth
- Boehringer Ingelheim and Micromet announce global collaboration for multiple myeloma BiTE antibody
- Bayer Schering Pharma and EndoCeutics Enter into a Global Agreement
- Merck Announces First-Quarter 2010 Financial Results
- FDA approved VIMOVO for arthritis patients at risk of developing NSAID-associated gastric ulcers